Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

Author:

Brown Janet E,Royle Kara-Louise,Gregory Walter,Ralph Christy,Maraveyas Anthony,Din Omar,Eisen Timothy,Nathan Paul,Powles Tom,Griffiths Richard,Jones Robert,Vasudev Naveen,Wheater Matthew,Hamid Abdel,Waddell Tom,McMenemin Rhona,Patel Poulam,Larkin James,Faust Guy,Martin Adam,Swain Jayne,Bestall Janine,McCabe Christopher,Meads David,Goh Vicky,Min Wah Tze,Brown Julia,Hewison Jenny,Selby Peter,Collinson Fiona,Carser Judith,Srinivasan Gopalakrishnan,Thistlewaite Fiona,Azzabi Ashraf,Beresford Mark,Farrugia David,Decatris Marios,Thomas Carys,Gale Joanna,McAleer James,Clayton Alison,Boleti Ekaterini,Geldart Thomas,Sundar Santhanam,Lester Jason,Palaniappan Nachi,Hingorani Mohan,Rehman Khaliq,Khan Mohammad,Sarwar Naveed,Graham Janine,Thomson Alastair,Srihari Narayanan,Sheehan Denise,Srinivasan Rajaguru,Khan Omar,Jane Worlding Andrew Stockdale,Boussios Stergios,Stuart Nicholas,MacDonald-Smith Carey,Danwata Falalu,McLaren Duncan,Sundaramurthy Aravindhan,Lydon Anna,Beesley Sharon,Lees Kathryn,Varughese Mohini,Gray Emma,Scott Angela,Baxter Mark,Mullard Anna,Innominato Pasquale,Kapur Gaurav,Kumar Anil,Charnley Natalie,Manetta Caroline,Chakraborti Prabir,Das Prantik,Rudman Sarah,Taylor Henry,Mikropoulos Christos,Highley Martin,Muthukumar Dakshinamoorthy,Zarkar Anjali,Vergis Roy,Sriprasad Seshadri,Brulinski Patryk,Clarke Amanda,Osbourne Richard,Harvey Melanie,Dega Renata,Sparrow Geoffrey,Barthakur Urmila,Beaumont Erica,Manetta Caroline,Michael Agnieszka,Porfiri Emilio,Azam Faisal,Kodavtiganti Ravi

Funder

National Institute for Health and Care Research

Health Technology Assessment Programme

University of Leeds

Publisher

Elsevier BV

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3